Evogene Ltd. (TLV:EVGN)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
409.40
+3.70 (0.91%)
Aug 5, 2025, 10:45 AM IDT
0.91%
Market Cap35.35M
Revenue (ttm)25.19M
Net Income (ttm)-56.63M
Shares Out8.71M
EPS (ttm)-9.24
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,127
Average Volume66,670
Open405.70
Previous Close405.70
Day's Range405.70 - 409.40
52-Week Range357.30 - 1,830.00
Beta1.41
RSI36.98
Earnings DateAug 14, 2025

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 117
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol EVGN
Full Company Profile

Financial Performance

In 2024, Evogene's revenue was $8.51 million, an increase of 50.90% compared to the previous year's $5.64 million. Losses were -$16.49 million, -30.96% less than in 2023.

Financial numbers in USD Financial Statements

News

Evogene Schedules Second Quarter 2025 Financial Results Release

Zoom conference call scheduled for August 19, 2025, 9:00 AM ET REHOVOT, Israel , July 29, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeti...

6 days ago - PRNewsWire

Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL

REHOVOT, Israel , July 8, 2025 /PRNewswire/ -- Evogene Ltd.  (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology ...

27 days ago - PRNewsWire

Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud

The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma and agriculture applications REHOVOT, Israel , June ...

7 weeks ago - PRNewsWire

Evogene Reports First Quarter 2025 Financial Results

Conference call and webcast: today, May 21, 2025, 9:00 am ET Financial Highlights: In the first quarter of 2025, total revenues were approximately $2.4 million, compared to approximately $4.2 million ...

2 months ago - PRNewsWire

Evogene Q1 2025 Earnings Preview

2 months ago - Seeking Alpha

Insights into Evogene's Upcoming Earnings

Evogene (NASDAQ: EVGN) is preparing to release its quarterly earnings on Wednesday, 2025-05-21. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

2 months ago - Benzinga

Evogene Schedules First Quarter 2025 Financial Results Release

Zoom conference call scheduled for May 21, 2025, 9:00 AM ET REHOVOT, Israel , May 8, 2025 /PRNewswire/ -- May 8, 2025 - Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology compan...

3 months ago - PRNewsWire

ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio

Lavie Bio improves agriculture productivity and sustainability through microbiome-based ag-biological products REHOVOT, Israel , April 21, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN)...

3 months ago - PRNewsWire

Evogene appoints Nir Nimrodi as new chair

5 months ago - Seeking Alpha

Evogene Reports Fourth Quarter and Full Year 2024 Financial Results

Conference call and webcast: today, March 6, 2025, 9:00 am ET Financial Highlights: In the year 2024, total revenues reached approximately $8.5 million compared to approximately $5.6 million in the ye...

5 months ago - PRNewsWire

Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025

Mr. Nir Nirmodi is Replacing Ms. Sarit Firon, who will Continue Serving as a Member of the Board REHOVOT, Israel , March 6, 2025 /PRNewswire/ -- Evogene Ltd.

5 months ago - PRNewsWire

Earnings Scheduled For March 6, 2025

Companies Reporting Before The Bell • Priority Tech Holdings (NASDAQ: PRTH) is expected to report quarterly earnings at $0.07 per share on revenue of $227.93 million. • KVH Industries (NASDAQ: KVHI)...

5 months ago - Benzinga

Evogene Q4 2024 Earnings Preview

5 months ago - Seeking Alpha

Evogene Schedules Fourth Quarter 2024 Financial Results Release

Zoom conference call scheduled for March 6, 2025, 9:00 AM ET REHOVOT, Israel , Feb. 20, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting...

5 months ago - PRNewsWire

AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease

Initial fungicidally active compounds already discovered REHOVOT, Israel , Feb. 13, 2025 /PRNewswire/ -- AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection pr...

6 months ago - PRNewsWire

Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities

Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities

9 months ago - GuruFocus

Evogene Reports Third Quarter 2024 Financial Results

Conference call and webcast: today, November 21, 2024, 9:00 am ET Financial Highlights: In the first nine months of 2024, total revenues reached approximately $6.9 million, compared to approximately $...

9 months ago - PRNewsWire

Evogene Q3 2024 Earnings Preview

9 months ago - Seeking Alpha

A Glimpse of Evogene's Earnings Potential

Evogene (NASDAQ: EVGN) will release its quarterly earnings report on Thursday, 2024-11-21. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Evogene to report an ea...

9 months ago - Benzinga